Since 1999, Acobiom has been providing gene expression profiles through sequencing (Next Generation Sequencing) technologies, proprietary bioinformatic programs and biostatistical algorithms. This high throughput platform is dedicated to the acquisition of genomic / transcriptomic data through the analysis of gene expression and accurate bioinformatic processes for identifying and quantifying gene/mRNA biomarkers. This platform can be used for identifying all the genes induced in each physiopathological situation in an exhaustive and sensitive manner. However, the genes are either already known or not and the genome of the organism is either sequenced or not.
Acobiom has been collaborating with several scientific teams for more than 18 years. Several partnerships have performed scientific publications.